SCHEMBL4348752

SCHEMBL4348752

Cc1cccc(C)c1NC(=O)Nc1cc(Cl)cc(Cl)c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 4/20 0.47
HSPA5 P11021 1/20 0.47
IDH1 O75874 2/20 0.45
LMNA P02545 2/20 0.44
HTT P42858 2/20 0.44
MAPT P10636 1/20 0.44
ALOX15 P16050 1/20 0.44
RAB9A P51151 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PYGL P06737 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MEN1 O00255 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.44
S1PR2 O95136 1/20 0.43
S1PR4 O95977 1/20 0.43
S1PR3 Q99500 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4350457 0.87 DDX3X (0.55) TRPV1HSPA5HTTMAPTALOX15
SCHEMBL4358635 0.84 TRPV1 (0.52) TRPV1LMNAHTTMAPTALOX15
SCHEMBL4351118 0.83 CXCL8 (0.44) TRPV1IDH1LMNAHTTMAPT
SCHEMBL6407982 0.82 HSPA5 (0.44) TRPV1HSPA5LMNAHTTMAPT
SCHEMBL4349966 0.82 TRPV1 (0.48) TRPV1IDH1LMNAHTTMAPT
SCHEMBL4359936 0.81 KCNMA1 (0.62) TRPV1IDH1LMNAHTTMAPT
SCHEMBL4353920 0.81 DHODH (0.60) TRPV1IDH1LMNAHTTMAPT
SCHEMBL6253485 0.78 POLB (0.48) TRPV1MAPTRAB9ANPSR1MEN1
SCHEMBL4358279 0.78 MEN1 (0.63) HSPA5LMNAHTTMAPTRAB9A
SCHEMBL4342033 0.78 RAB9A (0.61) TRPV1RAB9AMEN1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 TRPV1 2328/4885HSPA5 4499/4885IDH1 2740/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 TRPV1 2320/4885HSPA5 4585/4885IDH1 2326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.